Rejuvenation of RBCs: validation of a manufacturing method suitable for clinical use.
Peter A SmethurstJennifer JolleyRebecca BraundSue ProffittThomas LynesMatthew HazellPhil MellorKay RidgwellSimon ProcterAlexandra GriffithsAnthony M MarinakiHelen V NewGavin J MurphyDave EdmondsonRebecca Cardigannull nullPublished in: Transfusion (2019)
The validated rejuvenation process operates within defined quality limits, preserving RBC immunophenotypes, enabling manufacture for clinical trials.